Growing Revenue Stream Chroma's recent financial performance shows strong revenue growth primarily driven by its flagship product Niagen and NAD+ precursors, highlighting a substantial market demand which presents opportunities to expand sales efforts around health supplements and aging science.

Focus on Innovation With the company's recent rebranding to Niagen Bioscience and emphasis on NAD+ science, there is a clear strategic shift toward cutting-edge health and longevity solutions, suggesting potential for partnerships with biotech firms and healthtech distributors seeking advanced aging-related products.

Market Expansion Potential Chroma's engagement at notable events like the Roth Conference and its global presence in London, Brighton, and Sydney point toward opportunities to target international markets and collaborate with global health and wellness brands to accelerate product adoption.

E-commerce Growth Opportunity The company's reported boost in e-commerce sales indicates a strong direct-to-consumer channel that can be leveraged through targeted digital marketing campaigns and strategic promotional partnerships to increase market penetration and revenue.

Innovation in Aging Science Chroma's focus on NAD+ and healthy aging positions it well to collaborate with research institutions, medical device companies, and wellness providers interested in scientifically validated anti-aging solutions, expanding sales opportunities in health sciences and longevity markets.